Personalis Analyst Price Targets - Benzinga

Personalis Inc

PSNLNASDAQ

Trade with Public

Trade with Public

$16.83

0.10.6%

At close: Sep 2, 5:00 PM EST

$16.67

-0.06-0.36%

Pre-Market: 8:06 AM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Personalis Analyst Price Targets

Wall Street analyst price targets and consensus rating for Personalis (PSNL).

Price Target Range — 12 Quarters

Analyst Consensus — 6 Analysts

4Buy

2Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$13Upside to Avg. PT-20.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 20, 2026	Lake Street	Thomas Flaten	Downgrade	Buy→Hold	$16
Jul 20, 2026	BTIG	Mark Massaro	PT Raise	Buy	$11→$16
Jul 20, 2026	Needham	Mike Matson	Downgrade	Buy→Hold	—
Jul 17, 2026	Needham	Mike Matson	PT Raise	Buy	$12→$17
Jul 9, 2026	Morgan Stanley	Tejas Savant	PT Raise	Equal-Weight	$9→$13
May 12, 2026	Morgan Stanley	Tejas Savant	PT Cut	Equal-Weight	$10→$9
May 11, 2026	BTIG	Mark Massaro	PT Cut	Buy	$13→$11
Mar 5, 2026	Morgan Stanley	Tejas Savant	PT Cut	Equal-Weight	$11→$10
Feb 27, 2026	Needham	Mike Matson	PT Raise	Buy	$10→$12
Feb 11, 2026	BTIG	Mark Massaro	PT Raise	Buy	$12→$13
Jan 26, 2026	Guggenheim	Subbu Nambi	PT Raise	Buy	$12→$13
Jan 9, 2026	BTIG	Mark Massaro	Maintained	Buy	$12
Dec 2, 2025	Morgan Stanley	Tejas Savant	PT Raise	Equal-Weight	$9→$11
Nov 11, 2025	Morgan Stanley	Tejas Savant	PT Raise	Equal-Weight	$5→$9
Nov 11, 2025	Guggenheim	Subbu Nambi	PT Raise	Buy	$6→$12
Nov 11, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$10→$13
Nov 11, 2025	BTIG	Mark Massaro	PT Raise	Buy	$11→$12
Nov 6, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$9→$10
Nov 5, 2025	Needham	Mike Matson	PT Raise	Buy	$7→$10
Oct 22, 2025	BTIG	Mark Massaro	PT Raise	Buy	$6→$11

More with Benzinga EdgeGet Access

Analyst Ratings News

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Tempus AI acquires Personalis for $1.5B to target the $20B MRD cancer monitoring market. Get full deal details and analysis.

Vandana Singh

PRO
Lake Street Downgrades Personalis to Hold, Announces $16.25 Price Target

Lake Street analyst Thomas Flaten downgrades Personalis (NASDAQ:PSNL) from Buy to Hold and announces $16.25 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Personalis, Raises Price Target to $16.25

BTIG analyst Mark Massaro maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $11 to $16.25.

Benzinga Newsdesk

PRO
Needham Downgrades Personalis to Hold

Needham analyst Mike Matson downgrades Personalis (NASDAQ:PSNL) from Buy to Hold.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Personalis, Raises Price Target to $17

Needham analyst Mike Matson maintains Personalis (NASDAQ:PSNL) with a Buy and raises the price target from $12 to $17.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Personalis, Raises Price Target to $13

Morgan Stanley analyst Tejas Savant maintains Personalis (NASDAQ:PSNL) with a Equal-Weight and raises the price target from $9 to $13.

Benzinga Newsdesk